High relapse rates despite early intervention with intravenous methylprednisolone pulse therapy for severe childhood alopecia areata

Pediatric Dermatology

Volumn 32, Issue 4, 2015, Pages 481-487

  Smith, Alexandra ^a   Trüeb, Ralph M ^b   Theiler, Martin ^a,c   Hauser, Valérie ^d   Weibel, Lisa ^a,c  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b Center for Dermatology   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d Ostschweizer Children's Hospital   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENCYPRONE; METHOTREXATE; METHYLPREDNISOLONE; GLUCOCORTICOID;

ACNE VULGARIS; ADOLESCENT; ALLERGIC RHINITIS; ALOPECIA; ALOPECIA AREATA; ALOPECIA MULTILOCULARIS; ALOPECIA UNIVERSALIS; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; BRONCHOSPASM; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DISEASE DURATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG PULSE THERAPY; DRUG TOLERABILITY; EARLY INTERVENTION; ECZEMA; FAMILY HISTORY; FEMALE; FOLLOW UP; HAIR GROWTH; HAIR LOSS; HUMAN; MALE; METALLIC TASTE; MOOD CHANGE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SEVERE CHILDHOOD ALOPECIA AREATA; TREATMENT RESPONSE; PRESCHOOL CHILD; RECURRENT DISEASE; TREATMENT OUTCOME;

ADOLESCENT; ALOPECIA AREATA; CHILD; CHILD, PRESCHOOL; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; METHYLPREDNISOLONE; PULSE THERAPY, DRUG; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84937164679     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/pde.12578     Document Type: Article

References (29)

1. Price VH,. Alopecia areata: clinical aspects. J Invest Dermatol 1991; 96: 68S.
2. Safavi KH, Muller SA, Suman VJ, et al., Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 1995; 70: 628-633.
3. Xiao FL, Yang S, Liu JB, et al., The epidemiology of childhood alopecia areata in China: a study of 226 patients. Pediatr Dermatol 2006; 23: 13-18.
4. Gilhar A, Etzioni A, Paus R,. Alopecia areata. N Engl J Med 2012; 366: 1515-1525.
5. Ito T,. Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata. Clin Dev Immunol 2013; 2013: 348546.
6. McElwee KJ, Gilhar A, Tobin DJ, et al., What causes alopecia areata? Exp Dermatol 2013; 22: 609-626.
7. Weise K, Kretzschmar L, John SM, et al., Topical immunotherapy in alopecia areata: anamnestic and clinical criteria of prognostic significance. Dermatology 1996; 192: 129-133.
8. Goh C, Finkel M, Christos PJ, et al., Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venereol 2006; 20: 1055-1060.
9. Kar BR, Handa S, Dogra S, et al., Placebo-controlled oral pulse prednisolone therapy in alopecia areata. J Am Acad Dermatol 2005; 52: 287-290.
10. Tosti A, Bellavista S, Iorizzo M,. Alopecia areata: a long term follow-up study of 191 patients. J Am Acad Dermatol 2006; 55: 438-441.
11. Yang S, Yang J, Liu JB, et al., The genetic epidemiology of alopecia areata in China. Br J Dermatol 2004; 151: 16-23.
12. Friedli A, Labarthe MP, Engelhardt E, et al., Pulse methylprednisolone therapy for severe alopecia areata: an open prospective study of 45 patients. J Am Acad Dermatol 1998; 39: 597-602.
13. Seiter S, Ugurel S, Tilgen W, et al., High-dose pulse corticosteroid therapy in the treatment of severe alopecia areata. Dermatology 2001; 202: 230-234.
14. Harries MJ, Sun J, Paus R, et al., Management of alopecia areata. BMJ 2010; 341: c3671.
15. Salsberg JM, Donovan J,. The safety and efficacy of diphencyprone for the treatment of alopecia areata in children. Arch Dermatol 2012; 148: 1084-1085.
16. Al-Fouzan AS, Nanda A,. Alopecia in children. Clin Dermatol 2000; 18: 735-743.
17. Nakajima T, Inui S, Itami S,. Pulse corticosteroid therapy for alopecia areata: study of 139 patients. Dermatology 2007; 215: 320-324.
18. Sharma VK,. Pulsed administration of corticosteroids in the treatment of alopecia areata. Int J Dermatol 1996; 35: 133-136.
19. Kiesch N, Stene JJ, Goens J, et al., Pulse steroid therapy for children's severe alopecia areata? Dermatology 1997; 194: 395-397.
20. Hubiche T, Leaute-Labreze C, Taieb A, et al., Poor long term outcome of severe alopecia areata in children treated with high dose pulse corticosteroid therapy. Br J Dermatol 2008; 158: 1136-1137.
21. Friedland R, Tal R, Lapidoth M, et al., Pulse corticosteroid therapy for alopecia areata in children: a retrospective study. Dermatology 2013; 227: 37-44.
22. Sinha A, Bagga A,. Pulse steroid therapy. Indian J Pediatr 2008; 75: 1057-1066.
23. Ventura MT, Muratore L, Calogiuri GF, et al., Allergic and pseudoallergic reactions induced by glucocorticoids: a review. Curr Pharm Des 2003; 9: 1956-1964.
24. Royer M, Bodemer C, Vabres P, et al., Efficacy and tolerability of methotrexate in severe childhood alopecia areata. Br J Dermatol 2011; 165: 407-410.
25. Droitcourt C, Milpied B, Ezzedine K, et al., Interest of high-dose pulse corticosteroid therapy combined with methotrexate for severe alopecia areata: a retrospective case series. Dermatology 2012; 224: 369-373.
26. Joly P,. The use of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia totalis or universalis. J Am Acad Dermatol 2006; 55: 632-636.
27. Chartaux E, Joly P,. Long-term follow-up of the efficacy of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia areata totalis or universalis. Ann Dermatol Venereol 2010; 137: 507-513.
28. Huang KP, Mullangi S, Guo Y, et al., Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. JAMA Dermatol 2013; 149: 789-794.
29. Bilgic O, Bilgic A, Bahali K, et al., Psychiatric symptomatology and health-related quality of life in children and adolescents with alopecia areata. J Eur Acad Dermatol Venereol 2014; 28: 1463-1468.